Tuesday, December 2, 2008 - 11:10PM EST

Clinical Trials

21. Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.

Author
Park JY; Ahn SH; Yoon YJ; Kim JK; Lee HW; Lee do Y; Chon CY; Moon YM; Han KH;
Institution
Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Journal
Cancer. 2007 Jul 1;110(1):129-37.
Abstract URL
Click here to view abstract

22. Multiple-electrode radiofrequency ablation of hepatic malignancies: initial clinical experience.

Author
Laeseke PF; Frey TM; Brace CL; Sampson LA; Winter TC 3rd; Ketzler JR; Lee FT Jr;
Institution
Department of Biomedical Engineering, University of Wisconsin, Madison, WI, USA.
Journal
AJR Am J Roentgenol. 2007 Jun;188(6):1485-94.
Abstract URL
Click here to view abstract

23. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable.

Author
Kim TH; Kim DY; Park JW; Kim YI; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM;
Institution
Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Journal
Am J Clin Oncol. 2006 Dec;29(6):568-75.
Abstract URL
Click here to view abstract

24. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.

Author
Mazzaferro V; Romito R; Schiavo M; Mariani L; Camerini T; Bhoori S; Capussotti L; Calise F; Pellicci R; Belli G; Tagger A; Colombo M; Bonino F; Majno P; Llovet JM;
Institution
Department of Surgery, Biomedical Statistics, Pathology, National Cancer Institute of Milan and Chair of Gastroenterology, Policlinico Foundation, Department of Medicine, University of Milan, Italy. vincenzo.mazzaferro@istitutotumori.mi.it
Journal
Hepatology. 2006 Dec;44(6):1543-54.
Abstract URL
Click here to view abstract

25. Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial.

Author
Kumar A; Srivastava DN; Chau TT; Long HD; Bal C; Chandra P; Chien le T; Hoa NV; Thulkar S; Sharma S; Tam le H; Xuan TQ; Canh NX; Pant GS; Bandopadhyaya GP;
Institution
Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Journal
Radiology. 2007 May;243(2):509-19.
Abstract URL
Click here to view abstract

26. Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study.

Author
Louafi S; Boige V; Ducreux M; Bonyhay L; Mansourbakht T; de Baere T; Asnacios A; Hannoun L; Poynard T; Taieb J;
Institution
Service d'Hepato-gastro-enterologie, Groupe Hospitalier Pitie Salpetriere, Paris, France.
Journal
Cancer. 2007 Apr 1;109(7):1384-90.
Abstract URL
Click here to view abstract

27. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.

Author
Furst G; Schulte am Esch J; Poll LW; Hosch SB; Fritz LB; Klein M; Godehardt E; Krieg A; Wecker B; Stoldt V; Stockschlader M; Eisenberger CF; Modder U; Knoefel WT;
Institution
Institute of Diagnostic Radiology, Heinrich-Heine-University of Duesseldorf, Moorenstr 5, 40225 Duesseldorf, Germany.
Journal
Radiology. 2007 Apr;243(1):171-9. Epub 2007 Feb 20.
Abstract URL
Click here to view abstract

28. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.

Author
Nakazawa T; Kokubu S; Shibuya A; Ono K; Watanabe M; Hidaka H; Tsuchihashi T; Saigenji K;
Institution
Gastroenterology Division of Internal Medicine, Kitasato University East Hospital, 2-1-1 Asamizodai, Sagamihara, Kanagawa 228-8520, Japan. tnakazaw@kitasato-u.ac.jp
Journal
AJR Am J Roentgenol. 2007 Feb;188(2):480-8.
Abstract URL
Click here to view abstract

29. A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma.

Author
Lo CM; Liu CL; Chan SC; Lam CM; Poon RT; Ng IO; Fan ST; Wong J;
Institution
Centre for the Study of Liver Disease and the Department of Surgery, University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China. chungmlo@hkucc.hku.hk
Journal
Ann Surg. 2007 Jun;245(6):831-42.
Abstract URL
Click here to view abstract

30. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.

Author
Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M;
Institution
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, University of Tokyo, Japan.
Journal
Hepatology. 2006 Oct;44(4):891-5.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5